Song S H, Lee J K, Hur J Y, Kim I, Saw H S, Park Y K
Department of Obstetrics, School of Medicine, Korea University, Seoul, Republic of Korea.
Int J Gynecol Cancer. 2006 Nov-Dec;16(6):2009-17. doi: 10.1111/j.1525-1438.2006.00727.x.
The aim of this study was to investigate the correlations between human papillomavirus (HPV) load and vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), matrix metalloproteinase-2 (MMP-2), and cyclooxygenase-2 (COX-2), and to identify biomarkers that may predict high-risk HPV clearance or persistence after conization with negative margins. The following samples were analyzed: 77 paraffin-embedded specimens from patients with cervical intraepithelial neoplasia (CIN), including 27 CIN 2 conization specimens and 50 CIN 3 conization specimens. Immunohistochemical analysis was performed with antibodies to VEGF, EGFR, MMP-2, and COX-2. Hybrid capture II testing was used to detect HPV DNA. VEGF expression was significantly associated with HPV load (rho = 0.27186, P = 0.0191), while COX-2 expression was significantly and inversely associated with HPV load (rho = -0.34309, P = 0.0028). In univariate analysis, HPV load (P = 0.0112) and VEGF expression (P = 0.0274) were significantly associated with high-risk HPV clearance or persistence after conization with negative margins. In multiple regression analysis, high viral load (relative light unit/positive control > 500) and positive VEGF expression were significantly associated with high-risk HPV persistence after conization with negative margins (odds ratio [OR]: 9.915, CI: 1.891-51.994; OR: 6.661, CI: 1.208-36.722, respectively). In conclusion, VEGF expression is related to HPV load, while COX-2 expression is inversely related to HPV load, and immunohistochemical analysis of VEGF expression and HPV viral load are a significant and an independent prognostic indicator of high-risk HPV persistence after conization with negative margins.
本研究的目的是调查人乳头瘤病毒(HPV)载量与血管内皮生长因子(VEGF)、表皮生长因子受体(EGFR)、基质金属蛋白酶-2(MMP-2)和环氧化酶-2(COX-2)之间的相关性,并确定在切缘阴性的锥切术后可预测高危型HPV清除或持续存在的生物标志物。分析了以下样本:77例来自宫颈上皮内瘤变(CIN)患者的石蜡包埋标本,包括27例CIN 2锥切标本和50例CIN 3锥切标本。使用针对VEGF、EGFR、MMP-2和COX-2的抗体进行免疫组织化学分析。采用杂交捕获II检测法检测HPV DNA。VEGF表达与HPV载量显著相关(rho = 0.27186,P = 0.0191),而COX-2表达与HPV载量显著负相关(rho = -0.34309,P = 0.0028)。在单因素分析中,HPV载量(P = 0.0112)和VEGF表达(P = 0.0274)与切缘阴性的锥切术后高危型HPV清除或持续存在显著相关。在多因素回归分析中,高病毒载量(相对光单位/阳性对照>500)和VEGF表达阳性与切缘阴性的锥切术后高危型HPV持续存在显著相关(优势比[OR]:9.915,CI:1.891 - 51.994;OR:6.661,CI:1.208 - 36.722)。总之,VEGF表达与HPV载量相关,而COX-2表达与HPV载量负相关,VEGF表达和HPV病毒载量的免疫组织化学分析是切缘阴性的锥切术后高危型HPV持续存在的显著且独立的预后指标。